This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Avelos Therapeutics Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: The Innovative Contributions of Darren Le Grand
Introduction
Darren Le Grand is a notable inventor based in East Grinstead, GB. He has made significant contributions to the field of pharmaceuticals through his innovative research and development. His work focuses on compounds that have the potential to impact the treatment of serious medical conditions.
Latest Patents
Darren holds a patent for the "Preparation of substituted 1,2-diaminoheterocyclic compound derivatives and their use as pharmaceutical agents." This invention relates to compounds that act as microtubule associated serine/threonine-like kinase (MASTL) inhibitors. The compounds developed by Darren are aimed at treating diseases and medical conditions mediated by MASTL, including cancer and other related diseases.
Career Highlights
Darren is currently associated with Avelos Therapeutics Inc., where he continues to advance his research in pharmaceutical innovations. His work has garnered attention for its potential applications in treating various medical conditions.
Collaborations
Darren collaborates with talented individuals in his field, including Ki Seon Baek and Ja Heouk Khoo. These partnerships enhance the research and development process, leading to more effective solutions in the pharmaceutical industry.
Conclusion
Darren Le Grand's contributions to pharmaceutical innovation are noteworthy, particularly in the development of MASTL inhibitors. His work exemplifies the impact of dedicated research on advancing medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile